Adolfo Aramburu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Adolfo Aramburu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Carmen del Pilar Diaz-Parra
Humanify Centro de Bienestar Integral, Instituto de Investigación Nutricional - IIN, Lima, Peru
2 shared publications - Claudio F. Lanata
Instituto de Investigación Nutricional, Lima, Peru
2 shared publications - Gabriela Rojas-Limache
Humanify Centro de Bienestar Integral, Instituto de Investigación Nutricional - IIN, Lima, Peru
2 shared publications - Gandy Dolores-Maldonado
Escuela Salud Pública de México. Cuernavaca, Morelos, Mexico
2 shared publications - Giancarlo Alvarado-Gamarra
Instituto de Investigación Nutricional, Lima, Peru
2 shared publications - Karen Cueva Rodríguez
Humanify Centro de Bienestar Integral, Instituto de Investigación Nutricional - IIN, Lima, Peru
2 shared publications
Latest Publications
- Open Access
- 21 December 2024
- Published by Springer Nature in European Journal of Nutrition
- Vol. 64 (1) , 1-21
A comparative analysis of heme vs non-heme iron administration: a systematic review and meta-analysis of randomized controlled trials
Background and purpose Bioavailability studies and observational evidence suggest that heme iron (HI) may have greater impact on iron status indicators compared with non-heme iron (NHI). This systematic review and meta-analysis aimed to review the current evidence on the effect of the administration of HI compared with NHI for improving iron status in non-hospitalized population groups. Methods We searched Pubmed, CENTRAL, Scopus, Web of Science, and LILACS from inception to July 2024. There was no language restriction or exclusion based on age or iron status. Only randomized controlled trials comparing HI with NHI were considered. A random-effects meta-analysis was performed to compare the effect of treatments for iron status indicators and total side effects (including gastrointestinal side effects). We measured the certainty of the evidence (CoE) using GRADE assessment. Results After screening 3097 articles, 13 studies were included. Most of the interventions used HI in low doses combined with NHI. The meta-analysis showed higher hemoglobin increases in children with anemia or low iron stores receiving HI (MD 1.06 g/dL; 95% CI: 0.34; 1.78; CoE: very low). No statistically significant difference between interventions were found for any iron status indicator in the other population subgroups (CoE: very low). Participants receiving HI had a 38% relative risk reduction of total side effects compared to NHI (RR 0.62; 95% CI 0.40; 0.96; CoE: very low). Conclusion The current evidence comparing HI with NHI is very limited, preliminary findings suggest that interventions using HI may result in fewer side effects and may be superior in children with iron deficiency or anemia. However, given the very low certainty of the evidence, these results need further investigation through high-quality clinical trials. Protocol registration CRD42023483157.
- 21 December 2024
- Published by Springer Nature in European Journal of Nutrition
- Vol. 64 (1) , 1-21
Open AccessA comparative analysis of heme vs non-heme iron administration: a systematic review and meta-analysis of randomized controlled trials
Background and purpose Bioavailability studies and observational evidence suggest that heme iron (HI) may have greater impact on iron status indicators compared with non-heme iron (NHI). This systematic review and meta-analysis aimed to review the current evidence on the effect of the administration of HI compared with NHI for improving iron status in non-hospitalized population groups. Methods We searched Pubmed, CENTRAL, Scopus, Web of Science, and LILACS from inception to July 2024. There was no language restriction or exclusion based on age or iron status. Only randomized controlled trials comparing HI with NHI were considered. A random-effects meta-analysis was performed to compare the effect of treatments for iron status indicators and total side effects (including gastrointestinal side effects). We measured the certainty of the evidence (CoE) using GRADE assessment. Results After screening 3097 articles, 13 studies were included. Most of the interventions used HI in low doses combined with NHI. The meta-analysis showed higher hemoglobin increases in children with anemia or low iron stores receiving HI (MD 1.06 g/dL; 95% CI: 0.34; 1.78; CoE: very low). No statistically significant difference between interventions were found for any iron status indicator in the other population subgroups (CoE: very low). Participants receiving HI had a 38% relative risk reduction of total side effects compared to NHI (RR 0.62; 95% CI 0.40; 0.96; CoE: very low). Conclusion The current evidence comparing HI with NHI is very limited, preliminary findings suggest that interventions using HI may result in fewer side effects and may be superior in children with iron deficiency or anemia. However, given the very low certainty of the evidence, these results need further investigation through high-quality clinical trials. Protocol registration CRD42023483157.
- Open Access
- 3 December 2024
- Published by Springer Nature in Research Square
A comparative analysis of heme vs non-heme iron administration: a systematic review and meta-analysis of randomized controlled trials
Background and purpose: Bioavailability studies and observational evidence suggest that heme iron (HI) may have greater impact on iron status indicators compared with non-heme iron (NHI). This systematic review and meta-analysis aimed to review the current evidence on the effect of the administration of HI compared with NHI for improving iron status in non-hospitalized population groups. Methods: We searched Pubmed, CENTRAL, Scopus, Web of Science, and LILACS from inception to July 2024. There was no language restriction or exclusion based on age or iron status. Only randomized controlled trials comparing HI with NHI were considered. A random-effects meta-analysis was performed to compare the effect of treatments for iron status indicators and total side effects (including gastrointestinal side effects). We measured the certainty of the evidence (CoE) using GRADE assessment. Results: After screening 3097 articles, 13 studies were included. Most of the interventions used HI in low doses combined with NHI. The meta-analysis showed higher hemoglobin increases in children with anemia or low iron stores receiving HI (MD 1.06 g/dL; 95% CI: 0.34; 1.78; CoE: Very low). No statistically significant difference between interventions were found for any iron status indicator in the other population subgroups(CoE: Very low). Participants receiving HI had a 38% relative risk reduction of total side effects compared to NHI (RR 0.62; 95% CI 0.40; 0.96; CoE: Very low). Conclusion: The current evidence comparing HI with NHI is very limited, preliminary findings suggest that interventions using HI may result in fewer side effects and may be superior in children with iron deficiency. However, given the very low certainty of the evidence, these results need further investigation through high-quality clinical trials.
- 3 December 2024
- Published by Springer Nature in Research Square
Open AccessA comparative analysis of heme vs non-heme iron administration: a systematic review and meta-analysis of randomized controlled trials
Background and purpose: Bioavailability studies and observational evidence suggest that heme iron (HI) may have greater impact on iron status indicators compared with non-heme iron (NHI). This systematic review and meta-analysis aimed to review the current evidence on the effect of the administration of HI compared with NHI for improving iron status in non-hospitalized population groups. Methods: We searched Pubmed, CENTRAL, Scopus, Web of Science, and LILACS from inception to July 2024. There was no language restriction or exclusion based on age or iron status. Only randomized controlled trials comparing HI with NHI were considered. A random-effects meta-analysis was performed to compare the effect of treatments for iron status indicators and total side effects (including gastrointestinal side effects). We measured the certainty of the evidence (CoE) using GRADE assessment. Results: After screening 3097 articles, 13 studies were included. Most of the interventions used HI in low doses combined with NHI. The meta-analysis showed higher hemoglobin increases in children with anemia or low iron stores receiving HI (MD 1.06 g/dL; 95% CI: 0.34; 1.78; CoE: Very low). No statistically significant difference between interventions were found for any iron status indicator in the other population subgroups(CoE: Very low). Participants receiving HI had a 38% relative risk reduction of total side effects compared to NHI (RR 0.62; 95% CI 0.40; 0.96; CoE: Very low). Conclusion: The current evidence comparing HI with NHI is very limited, preliminary findings suggest that interventions using HI may result in fewer side effects and may be superior in children with iron deficiency. However, given the very low certainty of the evidence, these results need further investigation through high-quality clinical trials.
- Open Access
- 24 September 2020
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 37 (3) , 403-11
Ganancia de peso gestacional como predictor de macrosomía y bajo peso al nacer: revisión sistemática
Objetivos: Evaluar la capacidad predictiva de las recomendaciones de ganancia de peso gestacional respecto del bajo peso al nacer (BPN) y la macrosomía neonatal, propuestas por el Institute of Medicine (IOM) y el Centro Latinoamericano de Perinatología (CLAP). Materiales y métodos: La búsqueda bibliográfica se realizó en PubMed, Embase (vía Ovid), Cochrane Library, EBSCOhost, Scopus, LILACS y SciELO. La calidad metodológica se evaluó utilizando QUADAS 2. Resultados: Se obtuvieron 1192 artículos, cinco cumplieron los criterios de inclusión, ningún estudio evaluó las recomendaciones CLAP. La sensibilidad y especificidad para predecir el BPN y la macrosomía variaron largamente según el país de realización del estudio. En las cohortes de América Latina, la sensibilidad para predecir el BPN varió entre 62,8% y 74%, y la especificidad, entre 61,7% y 68%, mientras que la sensibilidad para predecir macrosomía fue 28,8%, y la especificidad, 43,8%. En la mayoría de estudios el valor predictivo positivo fue inferior al 25%, y el valor predictivo negativo, superior al 90%. La mayoría de los estudios tuvo alto riesgo de sesgo y problemas de aplicabilidad en la selección de pacientes. Conclusiones: La limitada calidad metodológica y representatividad de las cohortes estudiadas, probables factores de confusión no ajustados y modestos valores de sensibilidad y especificidad sugieren la necesidad de desarrollar estudios para establecer recomendaciones que se ajusten a las características epidemiológicas de la población peruana.
- 24 September 2020
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 37 (3) , 403-11
Open AccessGanancia de peso gestacional como predictor de macrosomía y bajo peso al nacer: revisión sistemática
Objetivos: Evaluar la capacidad predictiva de las recomendaciones de ganancia de peso gestacional respecto del bajo peso al nacer (BPN) y la macrosomía neonatal, propuestas por el Institute of Medicine (IOM) y el Centro Latinoamericano de Perinatología (CLAP). Materiales y métodos: La búsqueda bibliográfica se realizó en PubMed, Embase (vía Ovid), Cochrane Library, EBSCOhost, Scopus, LILACS y SciELO. La calidad metodológica se evaluó utilizando QUADAS 2. Resultados: Se obtuvieron 1192 artículos, cinco cumplieron los criterios de inclusión, ningún estudio evaluó las recomendaciones CLAP. La sensibilidad y especificidad para predecir el BPN y la macrosomía variaron largamente según el país de realización del estudio. En las cohortes de América Latina, la sensibilidad para predecir el BPN varió entre 62,8% y 74%, y la especificidad, entre 61,7% y 68%, mientras que la sensibilidad para predecir macrosomía fue 28,8%, y la especificidad, 43,8%. En la mayoría de estudios el valor predictivo positivo fue inferior al 25%, y el valor predictivo negativo, superior al 90%. La mayoría de los estudios tuvo alto riesgo de sesgo y problemas de aplicabilidad en la selección de pacientes. Conclusiones: La limitada calidad metodológica y representatividad de las cohortes estudiadas, probables factores de confusión no ajustados y modestos valores de sensibilidad y especificidad sugieren la necesidad de desarrollar estudios para establecer recomendaciones que se ajusten a las características epidemiológicas de la población peruana.